Combination Therapy with Reovirus and ATM Inhibitor Enhances Cell Death and Virus Replication in Canine Melanoma

Oncolytic virotherapy using reovirus is a promising new anti-cancer treatment with potential for use in humans and dogs. Because reovirus monotherapy shows limited efficacy in human and canine cancer patients, the clinical development of a combination therapy is necessary. To identify candidate comp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Oncolytics
Main Authors: Igase, Masaya, Shibutani, Shusaku, Kurogouchi, Yosuke, Fujiki, Noriyuki, Hwang, Chung Chew, Coffey, Matt, Noguchi, Shunsuke, Nemoto, Yuki, Mizuno, Takuya
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804779/
https://ncbi.nlm.nih.gov/pubmed/31650025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2019.08.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados